These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6970790)

  • 1. High-dose methotrexate with citrovorum factor rescue for patients with refractory lymphoproliferative disorders.
    Case DC
    J Maine Med Assoc; 1980 Dec; 71(12):355-8. PubMed ID: 6970790
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
    Jacobs SA; Santicky MJ
    Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
    Ettinger DS; Stanley KE; Nystrom JS
    Cancer Treat Rep; 1980; 64(10-11):1017-21. PubMed ID: 6970075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
    Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
    Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
    [No Abstract]   [Full Text] [Related]  

  • 7. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 8. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
    Paparopoli G; Agostara B; Di Girolamo G
    Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase II trial of high dose methotrexate with citrovorum factor "rescue" for hematological malignancies].
    Ueda T; Kubota Y; Saigo K; Tanaka T; Takubo T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
    Rinsho Ketsueki; 1982 Jun; 23(6):854-61. PubMed ID: 6983592
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient case involving high-dose methotrexate followed by leucovorin rescue.
    Alsop JA
    Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens.
    Villalba L; Hicks JE; Adams EM; Sherman JB; Gourley MF; Leff RL; Thornton BC; Burgess SH; Plotz PH; Miller FW
    Arthritis Rheum; 1998 Mar; 41(3):392-9. PubMed ID: 9506565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
    Levi M; Sulkes A; Katz E; Rizel S; Biran S
    Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].
    Vahrson H; Gorges K
    Med Klin; 1976 Oct; 71(41):1720-3. PubMed ID: 1086422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.
    Greco FA; Fer MF; Richardson RL; Hande KR; Van Boxtel CJ; Oldham RK
    Cancer Chemother Pharmacol; 1978; 1(4):255-7. PubMed ID: 373922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate and the citrovorum factor in the treatment of psoriasis.
    Ive FA; De Saram CF
    Trans St Johns Hosp Dermatol Soc; 1970; 56(1):45-7. PubMed ID: 5312493
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
    Henderson IC; Gelman R; Canellos GP; Frei E
    Cancer Treat Rep; 1981; 65 Suppl 1():67-75. PubMed ID: 6976832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancer.
    Barlow JJ; Piver MS
    Gynecol Oncol; 1979 Apr; 7(2):233-8. PubMed ID: 312234
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.